Hillsdale Investment Management’s Sensus Healthcare SRTS Stock Holding History

Hillsdale Investment Management’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38,800	Closed	-$268K	–	697
2024 Q4	$268K	Sell	38,800 -2,000	-5%	-$14.7K	0.01%	388
2024 Q3	$237K	Hold	40,800	–	–	0.02%	395
2024 Q2	$217K	Hold	40,800	–	–	0.02%	373
2024 Q1	$155K	Buy	+40,800	New	+$148K	0.01%	400
2023 Q2	–	Sell	-440,232	Closed	-$2.29M	–	649
2023 Q1	$2.29M	Sell	440,232 -30,000	-6%	-$215K	0.2%	149
2022 Q4	$3.49M	Sell	470,232 -74,104	-14%	-$668K	0.29%	128
2022 Q3	$6.82M	Sell	544,336 -102,200	-16%	-$1.22M	0.62%	33
2022 Q2	$4.96M	Buy	646,536 +47,100	+8%	+$395K	0.4%	80
2022 Q1	$6.07M	Buy	+599,436	New	+$5.48M	0.39%	67

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Hillsdale Investment Management's SRTS Position: Q1 2025 in Review

Hillsdale Investment Management sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 38,800 shares — an estimated $268K sold.

Hillsdale Investment Management first reported a position in SRTS in Q1 2022 and held it in 9 quarters. The position peaked at $6.82M in Q3 2022. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

Hillsdale Investment Management reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
Hillsdale Investment Management sold 38,800 Sensus Healthcare shares in Q1 2025, an estimated $268K.
Hillsdale Investment Management first reported a position in Sensus Healthcare in Q1 2022 and held it in 9 quarters.
Hillsdale Investment Management's Sensus Healthcare position peaked at $6.82M in Q3 2022.
53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on Hillsdale Investment Management's 13F filing for Q1 2025, filed 9 May 2025.